Apixaban for the Treatment of Cerebral Venous Sinus Thrombosis: A Single-Centre Experience and Systematic Review of the Literature.

Senta FrolMišo ŠabovičJanja Pretnar Oblak

Published in: CNS drugs (2023)

Our cases and the review of similar published cases, albeit obtained on a smaller scale, suggest that apixaban may be a safe and effective therapy for CVT. This assumption should be tested in a large randomised study.

Keyphrases

venous thromboembolism
atrial fibrillation
clinical trial
open label
subarachnoid hemorrhage
randomized controlled trial
systematic review
cerebral ischemia